GENEVA (Aug. 11, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a b...
hareholders approved all proposals by a large majority GENEVA (June 12, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: ...
Relief Therapeutics today published the agenda for its 2025 Annual General Meeting (AGM) of shareholders, to be held ...
Relief Therapeutics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its pate...
Relief Therapeutics today provided an update on the potential reverse merger with Renexxion, Inc. (Renexxion), a priv...
Relief Therapeutics today announced the full readout and compelling results from the clinical trial evaluating PKU GO...